Radiology Doctors in Kailua, HI Accepting Medicare

5 Radiology doctors found. Showing 1 - 5

Dr. Asti Pilika, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 611 Milokai Pl, Kailua, HI 96734 Phone: 084-162-9322    Fax: 855-673-9190

Calvin B. Delaplain, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1301 Aulepe St, Kailua, HI 96734 Phone: 808-263-1958

Carolyn Chen Clark, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 Ulukahiki St, Kailua, HI 96734 Phone: 503-251-6855

Dr. Norman T Ikemoto, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 640 Ulukahiki St, Kailua, HI 96734 Phone: 808-263-5166    Fax: 808-263-5167

Dr. Venerando Seguritan, MD Radiology - Vascular & Interventional Radiology Medicare: Accepting Medicare Assignments Practice Location: 640 Ulukahiki St, Kailua, HI 96734 Phone: 808-263-5166    Fax: 808-263-5167

News Archive

Study yields insights into shifts in epidemiology of multi-drug resistant organisms

A first-of-its-kind study of 900,000 hospital admissions from an integrated health system has yielded insights into shifts in the epidemiology of multi-drug resistant organisms (MDROs) in the community.

AI accurately predicts radiation therapy side effects for patients with head and neck cancers

For the first time, a sophisticated computer model has been shown to accurately predict two of the most challenging side effects associated with radiation therapy for head and neck cancer.

ArQule, Daiichi Sankyo announce decision to advance ARQ 197 into Phase 3 clinical trial for NSCLC

ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.

Sleep apnea is associated with cardiovascular risk factors among kidney transplant patients

Sleep apnea is common in individuals who receive a kidney transplant and is associated with increased risk of high blood pressure, heart disease or stroke, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

Read more Medical News

› Verified 1 days ago